
Consumer Staples · Packaged Foods & Meats
$46.55
+0.13%
Vol: 3.9M
Friday, June 19, 2026
McCormick (MKC) is approaching its Q2 2026 earnings report scheduled for June 25 with analyst estimates of $0.69 EPS and $1.92 billion in revenue. Two major developments define the near-term story: activist fund Toms Capital Investment Management disclosed a significant stake in MKC on May 29, signaling potential pressure for strategic change, and reports of a potential merger with Unilever's food business emerged that would create a $65 billion entity combining Knorr, Hellmann's, and McCormick's spice brands. JPMorgan maintained its Overweight rating but trimmed its price target to $63 from $64 on June 12 in its Q2 preview, while UBS lowered its target to $51 from $53 and maintained Neutral. Q1 2026 net sales grew 16.7% year-over-year (including 3.1% currency tailwind) supported by the McCormick de Mexico acquisition. The 40th consecutive year of dividend increases was authorized.
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
On June 13, 2026, Toms Capital Investment Management was reported to have built a significant stake in McCormick during Q2, after McCormick announced plans to acquire Unilever's food business. A successful takeover would create roughly a $65 billion sauce-and-spice company, adding brands such as Hellmann's mayonnaise alongside McCormick's French's mustard. The deal is expected to close by mid-2027, subject to regulatory and McCormick shareholder approval. The activist presence plus a transformational acquisition could shape McCormick's governance and capital allocation. The bear case is integration and financing risk on a large, leverage-adding deal, regulatory hurdles, and the long timeline to close, against a backdrop where UBS recently cut its target to $51 on softer food-sector demand.
McCormick's transformative merger with Unilever Foods (announced March 2026) would more than double sales to roughly $20B, with $600M/year in synergies expected by year three but near-term leverage rising to 4x. Unilever shareholders would initially own 55%, intending to retain around 10% post-deal. On May 1, McCormick secured a $2B term loan to fund the merger. The stock has fallen 38.1% over the past year as markets digest the integration risk. Q1 2026 results showed strong execution with net sales up 16.7% and margin expansion, with the heat portfolio (Frank's RedHot, Cholula) driving above-average growth. Among 13 analysts the consensus is Moderate Buy (7 Strong Buy, 6 Hold), with 9 analysts rating Buy as of May 12 and a $68.11 average 2026 price target implying 36.7% upside. Next earnings June 25.
McCormick announced a major combination with Unilever Foods that offers compelling cost synergies of roughly $600M/year by year three and global distribution opportunities, though the deal initially spooked markets as near-term leverage will rise to 4x and Unilever shareholders will own 55% of the combined entity. The company reported Q1 fiscal 2026 results (quarter ended Feb 28) with net sales up 16.7% (including 3.1% FX benefit) and organic sales growth of 1.2%, reaffirming its full-year 2026 sales, adjusted operating income, and adjusted EPS outlook. Bernstein maintained a Buy rating on May 13, and Deutsche Bank also kept a Buy. Wall Street analysts hold a consensus rating of Buy with an average price target of around $64-$68, implying about 33% upside from levels near $48 in mid-May. Shares have struggled, hitting a 52-week low of $46.82 versus a high of $78.16. Next earnings are scheduled for June 25.
McCormick shares finished the week down at $46.35, with the proposed merger with Unilever Foods continuing to weigh on sentiment due to financing and execution questions. The deal is expected to close by mid-2027 pending McCormick shareholder vote and regulatory clearance. On the fundamentals side, Q1 fiscal 2026 net sales rose 17% (helped by the McCormick de Mexico acquisition completed in January, lifting ownership to 75%) with organic growth of 1.2% and adjusted EPS of $0.66 vs $0.60 prior year. The company reaffirmed its fiscal 2026 outlook. Recent brand initiatives include collectible Old Bay tins, community scholarships, a Preakness Stakes partnership, and a MICA artist collaboration. According to 9 analysts, MKC carries a Buy consensus rating as of May 12, 2026. The stock faces ongoing pressure from rising costs and the deal-related overhang.
McCormick stock remained volatile with shares falling to $46.35 by week's end (started Monday at $48.49, hit $44.82 low Wednesday), as the proposed Unilever Foods tie-up continues to overhang the stock amid financing and execution concerns. McCormick secured a $2 billion term loan on May 1, 2026 to support the merger, which targets $600M/year in cost synergies by year three but raises near-term leverage to 4x with Unilever shareholders initially owning 55%. The deal is set to close by mid-2027 pending shareholder vote and regulatory clearance. Q1 results showed net sales up 17% and adjusted EPS at $0.66 (vs $0.60 prior year), aided by the McCormick de Mexico acquisition. Heat portfolio (Frank's RedHot, Cholula) drove above-average growth. Analyst consensus is Buy with average price target of $64.27 implying 33% upside.
McCormick & Company shares traded between $45.68 and $47.16 on May 15, 2026, last at $46.79, after falling 2.59% on May 11. Wall Street maintains a Hold consensus with an average price target of $64.27 implying 33% upside (14 analysts: 6 Buys, 8 Holds, per MarketBeat May 8). The Unilever Foods combination announcement continues to weigh on sentiment despite strong Q1 results with margin expansion and reaffirmed FY26 guidance — Unilever shareholders would initially own 55% and pro-forma leverage would rise to 4x, though the deal offers ~$600M of annual cost synergies by year three. McCormick previously completed its acquisition of an additional 25% in McCormick de Mexico (now 75%). Risk: deal complexity, leverage build-up, and broad food-industry headwinds continue to pressure the stock; next earnings June 25.
McCormick & Co stock hit a 52-week low of $46.80, down 28.8% YTD and 35.3% over the past year. The dominant story remains the $44.8 billion deal in which Unilever agreed to combine its foods business with McCormick, expected to close by mid-2027. Andrew Foust was appointed Chief Integration Officer to oversee the merger, while Patrick Davis became Interim President Americas. McCormick reported Q1 2026 EPS of $0.66 beating the $0.60 estimate by 10%, and the Board declared a $0.48 quarterly dividend. Recently launched products include the 2026 Flavor of the Year Black Currant with Sensoria experience, MISSION BBQ Sauces retail line, and Cholula's "Cho-lu-la!" summer campaign with three new products. Barclays cut its PT to $57 from $58 (Equal Weight); consensus PT of $67 implies 49.15% upside according to 10 analysts rating MKC as Buy.
McCormick & Company shares fell 2.59% on May 11, 2026 to $47.07, hitting a new 52-week low of $46.82 amid investor concerns about its pending Unilever Foods combination. The deal offers $600M/year in cost synergies by year three and global distribution upside, but near-term leverage will rise to 4x and Unilever shareholders will initially own 55% of the combined entity. The company secured a $2B term loan on May 1 to finance the merger and named a Chief Integration Officer. Despite the stock weakness, McCormick delivered strong Q1 results with adjusted EPS of ~$0.66 beating $0.60 consensus, robust margin expansion, and reaffirmed FY26 guidance. Wall Street maintains a Hold consensus with a $64.27 average price target implying 33% upside.
MKC traded between $46.82-$48.93 on May 11, with shares near 52-week lows as the planned combination with Unilever's food business (a $44.8B deal first unveiled March 31) faces ESG-related scrutiny from Unilever shareholders around sustainability and forestry standards. McCormick secured a $2B term loan on May 1 to fund the merger. Midwest Trust disclosed a 16.1% position increase in Q4. Bear case: 52-week-low pricing reflects investor caution on consumer-spending headwinds and cost inflation, and execution/regulatory risk on the Unilever deal could continue to weigh until closing milestones are reached.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| MKCMCCORMICK | $46.55 | +0.13% | -0.1% | 14.0x | 0.64 | $12.5B |
| MDLZMONDELEZ | $60.11 | -1.24% | -2.8% | 17.8x | 0.40 | $77.2B |
| HSYHERSHEY | $172.52 | -1.59% | -9.5% | 17.4x | 0.08 | $35.0B |
| KHCKRAFT | $22.81 | -1.70% | -3.0% | 10.9x | 0.08 | $27.1B |
| TSNTYSON | $55.48 | -1.29% | -16.6% | 12.2x | 0.38 | $19.5B |
| GISGENERAL | $33.43 | +0.21% | -0.6% | 10.6x | -0.04 | $17.8B |
Price below 200d MA — bearish structure.